TYRO3 is also highly expressed in certain human malignancies, including leiomyosarcoma65, melanoma66, leukemia, and lung cancer67, with TYRO3 genetic knockdown slowing down tumor growth in vitro through unknown mechanisms65–67. Here, TYRO3 is linked to leukemia.